Halozyme Therapeutics
HALO
#1699
Rank
S$16.04 B
Marketcap
S$141.38
Share price
0.53%
Change (1 day)
70.12%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): S$0.75 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$1.66 Billion. In 2025 the company made an earning of S$0.59 Billion a decrease over its 2024 earnings that were of S$0.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.75 B26.02%
2025 S$0.59 B-16.2%
2024 S$0.71 B59.94%
2023 S$0.44 B39.94%
2022 S$0.31 B0.16%
2021 S$0.31 B92.2%
2020 S$0.16 B-278.96%
2019 -S$92.52 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$78.88 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$41.27 Million-52.86%
2014 -S$87.55 Million-18.09%
2013 -S$0.11 Billion55.88%
2012 -S$68.57 Million169.94%
2011 -S$25.41 Million-63.44%
2010 -S$69.48 Million-7.19%
2009 -S$74.85 Million15.91%
2008 -S$64.58 Million83.89%
2007 -S$35.12 Million78.1%
2006 -S$19.72 Million16%
2005 -S$17 Million45.24%
2004 -S$11.71 Million682.42%
2003 -S$1.5 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.55 B 4,392.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.84 B 1,084.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$43.01 B 5,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.16 B 1,127.47%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-S$0.62 Billion-182.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-S$62.3 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA